The 不良研究所 Clinical Innovation Competition (CLIC) was created to inspire innovative thinkers within the Faculty of Medicine and across 不良研究所 to imagine new devices, diagnostics, platforms, programs and processes that will improve health care, in Canada and globally.
The second edition of the 不良研究所 CLIC roused overwhelming interest across the 不良研究所-affiliated network, inciting forty-five teams to submit proposals with the potential to have a real and lasting impact on patient care.
On May 22, finalist teams pitched their innovative projects before a full room of enthusiastic supporters and an esteemed panel of judges at the 2019 不良研究所 CLIC Awards Ceremony, presided over by Dr. David Eidelman, Vice-Principal (Health Affairs) and Dean of Medicine. 鈥淥nce again this year, the quality of the proposals clearly demonstrates that we have the potential to make a tremendous impact, with the right vision and supports in place,鈥� remarked Dr. Eidelman.
Dr. Jake Barralet, Director of Innovation at the Steinberg Centre for Simulation and Interactive Learning (SCSIL), has developed a robust mentorship network through partnerships with 不良研究所 faculty and industry leaders. 鈥淲e are in a unique age, where accessibility of technology means that there is almost no facet of medicine that is not being transformed by it; this is a great time to be building networks to support medical innovation,鈥� said Dr. Barralet.
Dr. Raymond Hakim, Mrs. Marika Zelenka Roy (in partnership with the Montreal General Hospital Foundation), Dr. Kevin Lachapelle, Interim Executive Director of the SCSIL, and Dr. Don Sheppard, Director of the 不良研究所 Interdisciplinary Initiative in Infection and Immunity (MI4), assisted during the conferring of the awards for their respective prizes. In addition to cash prizes, the winning teams will be provided with access to start-up support and expertise, thanks to our generous sponsors and partners, BCF, CENTECH, Fasken, NOVO, and the Dobson Centre for Entrepreneurship.
We are grateful to our esteemed judges for their tremendous enthusiasm, expertise, time and support.
And the winners are鈥�
RE3 Therapeutics
Winner of the Hakim Family Innovation Prize
不良研究所 alumnus Dr. Raymond Hakim was the inspiration for the 不良研究所 CLIC. He created the Hakim Family Innovation Prize because he believes that, 鈥渨hen it comes to patients鈥� health care, we should always try to do better 鈥� by innovating and creating new products, programs and procedures, or novel health care delivery models.鈥� This award recognizes ideas, new processes or devices in health care with potential to have a tangible and meaningful impact on the patients entrusted to our care.
This prize was awarded to Professor Uri Saragovi of RE3 Therapeutics. He has developed a simple blood-test for quantitative detection of ovarian cancer tumor markers that would allow for earlier detection and a greater opportunity for curative therapy.
BetaSense
Winner of the Marika Zelenka Roy Innovation Prize
Marika Zelenka Roy, one of the first female students to graduate from electrical engineering at 不良研究所, believes that 鈥�by working in collaboration, innovative solutions to better patient care will emerge.鈥� This award, offered in collaboration with the , recognizes the best solution to an unmet clinical need for the care of a patient and the highest likelihood of success in being translated.
This prize was awarded to BetaSense. This team has developed a high performing detector that would allow nuclear medicine imaging techniques to be performed non-invasively in a greater number of clinics.
Antibiotic Sentinel
Winner of the MI4 Innovation Prize
This award, sponsored by the 不良研究所 Interdisciplinary Initiative in Infection and Immunity, recognizes a preventative, diagnostic or therapeutic innovative approach designed to address infectious or immune-related threats to human health.
Dr. Don Sheppard, Director of the MI4, presented this award to Antibiotic Sentinel. This team has developed a web-based application that provides up-to-the-minute information to help doctors select the best antibiotic to maximize the chance of curing an infection while minimizing harmful side effects.
FemTherapeutics
Winner of the Steinberg Centre Simnovation Prize
This award is sponsored by the Steinberg Centre for Simulation and Interactive Learning (SCSIL), and recognizes a trainee-led (student, resident or fellow) clinical innovation that has the greatest promise to develop into a truly competitive value proposition.
Dr. Kevin Lachapelle, Interim Executive Director of the SCSIL, presented this award to FemTherapeutics. This team has developed a solution to treat Pelvic Organ Prolapse (POP) a condition that 1 in every 10 women is diagnosed with, through a customized pessary.
Congratulations to all of the participants for their exceptional projects. For more information on the teams and finalists, please visit our website.
Until next year, we encourage you to keep innovating for better patient care.
听
All photo credits:听Joni Dufour and Owen Egan
